BGM
BGM Group Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$0.29
+0.71%Margins
Gross margin
13.4%
EBITDA margin
-20.5%
EBIT margin
-20.5%
Net margin
-29.9%
FCF margin
-6.1%
-5.8%
Return on equity
-5.2%
Return on assets
-3.9%
Return on invested capital
0.18x
Asset turnover
-$1.4M
Cash from operations
$0.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026